SprintRay

HardwareLos Angeles, California, USAFounded 2014· One of 1805 Hardware companies tracked by AMPulse

Leading dental 3D printing company providing chairside and laboratory 3D printers, resins, and software for dental professionals to create crowns, dentures, aligners, surgical guides, and more.

CEO / Founder: Amir Mansouri
Team Size: 201-500
Stage: Active
Total Funding: $100M
Latest Round: Series D
Key Investors: SoftBank Vision Fund; Acceleration International; Being Capital; CDBI Partners; Marathon Venture Partners

Technology & Products

Key Products

SprintRay offers 3D printing products including RayWare Cloud, RayWare Desktop, Pro Wash/Dry, ProCure 2, and a range of SprintRay and partner materials. They also have a BioMaterial Innovation Lab for next-generation resins.

Technological Advantage

High-speed, precise 3D printing with patented STEM Tank™ technology and Digital Press Stereolithography.

Differentiation

Value Proposition

Provides integrated, user-friendly 3D printing solutions that streamline dental workflows, enhance patient care, and enable efficient chairside production of dental appliances.

How They Differentiate

SprintRay differentiates itself by offering dental-specific 3D printers and solutions, emphasizing fast and accurate in-house printing. Their acquisition of EnvisionTEC's dental portfolio further strengthens their position with over 200 additional patents and two decades of dental innovation.

Market & Competition

Target Customers

Dental professionals including dentists, orthodontists, oral surgeons, and dental laboratories requiring chairside and lab-based 3D printing for restorative, prosthetic, and surgical applications.

Industry Verticals

Dental, Orthodontics, Dental Laboratories

Competitors

LuxCreo, Formlabs, Asiga, KeRunXi Medical, Mogassam, AngelAlign

Growth & Milestones

Growth Metrics

Series D funding: $100M+ led by SoftBank Vision Fund II (Oct 2022). Sep 2025: Acquired EnvisionTEC/ETEC dental portfolio from Desktop Health. Growing global presence with partnerships with Solventum (Mar 2025) and Ivoclar (2025). E&Y 2025 Greater Los Angeles Entrepreneur of the Year Award winner (Jun 2025).

Major Milestones

2014: Founded at USC Viterbi School of Engineering, Los Angeles, 2019: Released SprintRay Pro for dental clinics and labs, 2022 Oct: Raised $100M+ Series D led by SoftBank Vision Fund II, 2025 Mar: Partnership with Solventum for dental 3D printing, 2025: Partnership with Ivoclar for digital denture fabrication, 2025 Jun: Won E&Y Entrepreneur of the Year Award (Greater Los Angeles), 2025 Sep: Acquired EnvisionTEC/ETEC dental portfolio from Desktop Health

Notable Customers

NYU Dental School (for special procedures)

https://sprintray.com

Recent coverage of SprintRay

Why this company matters

AMPulse analysis, not a company disclosure

SprintRay occupies a focused position in additive manufacturing as a vertically integrated dental 3D printing company. Founded in 2014 out of USC Viterbi School of Engineering, the company targets the shift from outsourced lab production to in-office digital workflows. Its value proposition centers on speed and ease of use for dentists, orthodontists, and dental labs, distinguishing it from general-purpose polymer printer makers.

The core technology combines Digital Press Stereolithography with proprietary STEM Tank technology for high-speed, precise layer curing. SprintRay's product line includes the Pro series printers, post-processing systems (Pro Wash/Dry, ProCure 2), and cloud-based software RayWare for file management and print preparation. The company also operates a BioMaterial Innovation Lab to develop next-generation dental resins for restorative, prosthetic, and orthodontic applications.

Customers span chairside dental practices and large dental laboratories. Notable users include NYU Dental School for specialized procedures. SprintRay has formed strategic partnerships with Solventum for dental materials and Ivoclar for digital denture fabrication, extending its material ecosystem. The company raised over $100 million in Series D funding led by SoftBank Vision Fund in 2021 and acquired EnvisionTEC's dental portfolio from Desktop Health in 2025, adding more than 200 patents to its IP base.

SprintRay's competitive moat lies in its end-to-end workflow integration and dental-specific IP portfolio. However, it faces pressure from Formlabs, LuxCreo, and Asiga, which also target dental applications with general-purpose or specialized hardware. The company's ability to maintain its lead depends on continued resin innovation and deepening partnerships with major dental material suppliers.